John Mazarakis
CEO
Replay available
Vireo Growth Inc (OTC: VREOF) Q2 2026 earnings conference call, held 2026-08-11. Replay captured from the company's public earnings webcast.

CEO
Analyst, Zoanic and Associates
Hello everyone. Thank you for joining us and welcome to the Vireo Growth Q2 2026 Financial Results Call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star 1 to raise your hand. To withdraw your question, press star 1 again. I will now hand the conference over to John Mazarakis, CEO. John, please go ahead. Thank you, operator, and good morning, everyone. The second quarter was another important step forward for Vireo. We delivered strong financial performance while continuing to execute against what we believe is one of the most differentiated growth strategies in the cannabis industry. Tyson will review our financial results in a moment, but first I'd like to discuss our progress, our expanding platform, and then spend a few minutes discussing the strategy that's driving these investments. We closed several important transactions over the last few months, including Eves, Hawthorne, and the Bridgewell agribusiness. In addition, we announced several transformative transactions during the second quarter, that should significantly expand our platform, including the acquisition of Fluent to expand and deepen in Florida, C21 to broaden our Nevada presence with a strong operator, and Planet 13 that further solidifies both Nevada and cements our presence in Florida with a total of over 100 dispensaries. In July, we also announced two significant strategic transactions that further strengthen our platform. Thank you for joining us. Let me spend a few minutes here on some of the larger transactions I just covered. Bridgewell is part of our non-cannabis segment along with Hawthorne and is an important example of how we're thinking beyond the traditional cannabis operator model. It expands our ancil...